AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 61 filers reported holding AVROBIO INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $18,196,000 | -26.6% | 1,305,307 | -31.5% | 0.28% | -42.6% |
| Q3 2020 | $24,807,000 | -25.4% | 1,905,307 | 0.0% | 0.49% | -32.8% |
| Q2 2020 | $33,248,000 | +12.1% | 1,905,307 | 0.0% | 0.72% | -24.7% |
| Q1 2020 | $29,647,000 | +12.8% | 1,905,307 | +46.0% | 0.96% | +29.7% |
| Q4 2019 | $26,276,000 | +42.6% | 1,305,307 | 0.0% | 0.74% | +21.5% |
| Q3 2019 | $18,431,000 | +22.0% | 1,305,307 | +40.5% | 0.61% | +32.7% |
| Q2 2019 | $15,104,000 | -26.3% | 928,891 | 0.0% | 0.46% | -34.9% |
| Q1 2019 | $20,482,000 | +37.5% | 928,891 | 0.0% | 0.70% | +6.8% |
| Q4 2018 | $14,901,000 | -67.9% | 928,891 | 0.0% | 0.66% | -61.3% |
| Q3 2018 | $46,421,000 | +81.6% | 928,891 | 0.0% | 1.70% | +60.7% |
| Q2 2018 | $25,560,000 | – | 928,891 | – | 1.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 4,520,863 | $5,968,000 | 0.76% |
| Aisling Capital Management LP | 1,009,779 | $1,333,000 | 0.72% |
| MPM BioImpact LLC | 647,918 | $855,000 | 0.23% |
| GMT CAPITAL CORP | 2,594,914 | $3,425,000 | 0.22% |
| New Leaf Venture Partners, L.L.C. | 315,550 | $417,000 | 0.21% |
| GSA CAPITAL PARTNERS LLP | 338,422 | $447,000 | 0.06% |
| Penn Mutual Asset Management, LLC | 37,306 | $49,000 | 0.06% |
| Eversept Partners, LP | 295,369 | $389,887 | 0.03% |
| XTX Topco Ltd | 23,289 | $31,000 | 0.01% |
| Colonial River Wealth Management, LLC | 17,636 | $23,000 | 0.01% |